Auxiliary agents for the peroral administration of peptide and protein drugs: Synthesis and evaluation of novel pepstatin analogues

Journal of Medicinal Chemistry

Volumn 41, Issue 13, 1998, Pages 2339-2344

  Kratzel, Martin ^a   Hiessböck, Romana ^a   Bernkop Schnürch, Andreas ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Inst of Pharmaceutical Technology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOALCOHOL; EPIDERMAL GROWTH FACTOR; HORSERADISH PEROXIDASE; PEPSIN A; PEPSTATIN DERIVATIVE; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE;

ARTICLE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; ENZYME INHIBITION; ORAL DRUG ADMINISTRATION; PROTEIN DEGRADATION;

ADMINISTRATION, ORAL; DRUG DELIVERY SYSTEMS; EPIDERMAL GROWTH FACTOR; HORSERADISH PEROXIDASE; HYDROLYSIS; PEPSIN A; PEPSTATINS; PEPTIDES; PROTEASE INHIBITORS; PROTEINS;

EID: 0032543525     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980015w     Document Type: Article

References (13)

1. Bernkop-Schnürch, A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J. Control. Release, in press.
2. Bernkop-Schnürch, A.; Schwarz, G. H.; Kratzel, M. Modified Mucoadhesive Polymers for the Peroral Administration of Mainly Elastase Degradable Therapeutic (Poly)peptides. J. Control. Release 1997, 47, 113-121.
3. Bernkop-Schnürch, A.; Bratengeyer, I.; Valenta, C. Development of a drug delivery system protecting from trypsinic degradation. Int. J. Pharm. 1997, 157, 17-25.
4. Cho, Y.-K.; Rebholz, K. L.; Northrop, D. B. Solvent Isotope Effects on the Onset of Inhibition of Porcine Pepsin by Pepstatin. Biochemistry 1994, 33, 9637-9642.
5. Itoh, M.; Matsuo, Y. Gastric ulcer treatment with intravenous human epidermal growth factor: A double-blind controlled clinical study. J. Gastroenterol. Hepatol. 1994, 9, 78-83.
6. Slomiany, B. L.; Nishikawa, H.; Bilski, J.; Slomiany, A. Colloidal Bismuth Subcitrate Inhibits Peptic Degradation of Gastric Mucus and Epidermal Growth Factor in Vitro. Am. J. Gastroenterol. 1990, 85, 390-393.
7. Bernkop-Schnürch, A.; Dundalek, K. Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation. Int. J. Pharm. 1996, 138, 75-83.
8. Carmel, R. In vitro studies of gastric juice in patients with food-cobalamin mal absorption. Digest. Dis. Sci. 1994, 39, 2516-2522.
9. McCaffrey, G.; Jamieson, J. C. Evidence for the role of a cathepsin D-like activity in the release of gal β1-4 glcnac α2-6 sialyltransferase from rat and mouse 1 liver in whole-cell systems. Comp. Biochem. Phys. C. 1993, 104, 91-94.
10. Plumpton, C.; Kalinka, S.; Martin, R. C.; Horton, J. K.; Davenport, A. P. Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells-measurement by two-site enzyme-linked immunosorbent assays. Clin. Sci. 1994, 87, 245-251.
11. McConnell, R. M.; Frizzell, D.; Evans, A. C. A.; Jones, W.; Cagle, C. New Pepstatin Analogues: Synthesis and Pepsin Inhibition. J. Med. Chem. 1991, 34, 2298-2300.
12. Basha, A.; Lipton, M.; Weinreb, S. M. Tetrahedron Lett. 1977, 48, 4171-4172.
13. Kano, S.; Yokomatsu, T.; Iwasawa, H.; Shibuya, S. Tetrahedron Lett. 1987, 28, 6331- 6334 and literature cited therein.